Stocksigma LogoStocksigma Logo

Sai Parenterals Acquires 60% Stake in Prathyak Laboratories for Rs 15 Crore

On 5th Oct'26, Sai Parenterals completed the acquisition of a 60% equity stake in Hyderabad-based R&D center Prathyak Laboratories for Rs

Sai Parenterals Acquires 60% Stake in Prathyak Laboratories for Rs 15 Crore

Sai Parenterals Ltd 路 Press Release 路 05 Oct 2026, 9:12 pm

Sai Parenterals Acquires 60% Stake in Prathyak Laboratories for Rs 15 Crore On 5th Oct'26, Sai Parenterals completed the acquisition of a 60% equity stake in Hyderabad-based R&D center Prathyak Laboratories for Rs. 15 crore, funded via unutilized IPO proceeds. The acquisition replaces its planned greenfield R&D facility, adding 28 scientists and a pipeline of 150 SKUs across 86 molecules in complex and oncology injectables. Sai Parenterals holds a Right of First Refusal to acquire the remaining 40% at the same valuation via internal accruals, strengthening its regulated-market injectable franchise and Australia-New Zealand supply commitments.

Original exchange filing (PDF)

More announcements from Sai Parenterals Ltd

All Sai Parenterals Ltd announcements